Portal vein thrombosis in liver cirrhosis

World Journal of Hepatology

Volumn 6, Issue 2, 2014, Pages 64-71

  Kinjo, Nao ^a,b   Kawanaka, Hirofumi ^a   Akahoshi, Tomohiko ^a   Matsumoto, Yoshihiro ^a   Kamori, Masahiro ^a   Nagao, Yoshihiro ^a   Hashimoto, Naotaka ^a   Uehara, Hideo ^a   Tomikawa, Morimasa ^a   Shirabe, Ken ^a   Maehara, Yoshihiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b NATIONAL KYUSHU CANCER CENTER   (Japan)

Author keywords

Anticoagulation; Liver cirrhosis; Portal vein thrombosis; Splenectomy; Thrombophilic factors

Indexed keywords

EID: 84894472474     PISSN: None     EISSN: 19485182     Source Type: Journal    
DOI: 10.4254/wjh.v6.i2.64     Document Type: Short Survey

References (87)

1. Cohen J, Edelman RR, Chopra S. Portal vein thrombosis: a review. Am J Med 1992; 92: 173-182 [PMID: 1543202 DOI: 10.1016/0002-9343(92)90109-O]
2. Janssen HL, Wijnhoud A, Haagsma EB, van Uum SH, van Nieuwkerk CM, Adang RP, Chamuleau RA, van Hattum J, Vleggaar FP, Hansen BE, Rosendaal FR, van Hoek B. Extrahepatic portal vein thrombosis: aetiology and determinants of survival. Gut 2001; 49: 720-724 [PMID: 11600478 DOI: 10.1136/gut.49.5.720]
3. Condat B, Pessione F, Hillaire S, Denninger MH, Guillin MC, Poliquin M, Hadengue A, Erlinger S, Valla D. Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy. Gastroenterology 2001; 120: 490-497 [PMID: 11159889 DOI: 10.1053/gast.2001.21209]
4. Francoz C, Belghiti J, Vilgrain V, Sommacale D, Paradis V, Condat B, Denninger MH, Sauvanet A, Valla D, Durand F. Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation. Gut 2005; 54: 691-697 [PMID: 15831918 DOI: 10.1136/gut.2004.042796]]
5. Condat B, Pessione F, Helene Denninger M, Hillaire S, Valla D. Recent portal or mesenteric venous thrombosis: increased recognition and frequent recanalization on anticoagulant therapy. Hepatology 2000; 32: 466-470 [PMID: 10960436]
6. DeLeve LD, Valla DC, Garcia-Tsao G. Vascular disorders of the liver. Hepatology 2009; 49: 1729-1764 [PMID: 19399912 DOI: 10.1002/hep.22772]
7. Tsochatzis EA, Senzolo M, Germani G, Gatt A, Burroughs AK. Systematic review: portal vein thrombosis in cirrhosis. Aliment Pharmacol Ther 2010; 31: 366-374 [PMID: 19863496 DOI: 10.1111/j.1365-2036.2009.04182.x]
8. Amitrano L, Guardascione MA. Management of portal vein thrombosis in cirrhotic patients. Mediterr J Hematol Infect Dis 2009; 1: e2009014 [PMID: 21415954 DOI: 10.4084/MJHID.2009.014]
9. Okuda K, Ohnishi K, Kimura K, Matsutani S, Sumida M, Goto N, Musha H, Takashi M, Suzuki N, Shinagawa T. Incidence of portal vein thrombosis in liver cirrhosis. An angiographic study in 708 patients. Gastroenterology 1985; 89: 279-286 [PMID: 4007419]
10. Gaiani S, Bolondi L, Li Bassi S, Zironi G, Siringo S, Barbara L. Prevalence of spontaneous hepatofugal portal flow in liver cirrhosis. Clinical and endoscopic correlation in 228 patients. Gastroenterology 1991; 100: 160-167 [PMID: 1983817]
11. Amitrano L, Guardascione MA, Brancaccio V, Margaglione M, Manguso F, Iannaccone L, Grandone E, Balzano A. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J Hepatol 2004; 40: 736-741 [PMID: 15094219 DOI: 10.1016/j.jhep.2004.01.001]
12. Nonami T, Yokoyama I, Iwatsuki S, Starzl TE. The incidence of portal vein thrombosis at liver transplantation. Hepatology 1992; 16: 1195-1198 [PMID: 1427658 DOI: 10.1002/hep.1840160515]
13. Yerdel MA, Gunson B, Mirza D, Karayalçin K, Olliff S, Buckels J, Mayer D, McMaster P, Pirenne J. Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome. Transplantation 2000;69: 1873-1881 [PMID: 10830225 DOI: 10.1097/00007890-200005150-00023]
14. Charco R, Fuster J, Fondevila C, Ferrer J, Mans E, García-Valdecasas JC. Portal vein thrombosis in liver transplantation. Transplant Proc 2005; 37: 3904-3905 [PMID: 16386579 DOI: 10.1016/j.transproceed.2005.09.120]
15. Manzanet G, Sanjuán F, Orbis P, López R, Moya A, Juan M, Vila J, Asensi J, Sendra P, Ruíz J, Prieto M, Mir J. Liver transplantation in patients with portal vein thrombosis. Liver Transpl 2001; 7: 125-131 [PMID: 11172396 DOI: 10.1053/jlts.2001.21295]
16. Thompson EN, Sherlock S. The aetiology of portal vein thrombosis with particular reference to the role of infection and exchange transfusion. Q J Med 1964; 33: 465-480 [PMID: 14212603]
17. Montalto P, Vlachogiannakos J, Cox DJ, Pastacaldi S, Patch D, Burroughs AK. Bacterial infection in cirrhosis impairs coagulation by a heparin effect: a prospective study. J Hepatol 2002; 37: 463-470 [PMID: 12217599 DOI: 10.1016/S0168-8278(02)00208-8]
18. van't Riet M, Burger JW, van Muiswinkel JM, Kazemier G, Schipperus MR, Bonjer HJ. Diagnosis and treatment of portal vein thrombosis following splenectomy. Br J Surg 2000; 87: 1229-1233 [PMID: 10971433 DOI: 10.1046/j.1365-2168.2000.01514.x]
19. Amitrano L, Brancaccio V, Guardascione MA, Margaglione M, Iannaccone L, D'Andrea G, Marmo R, Ames PR, Balzano A. Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis. Hepatology 2000; 31: 345-348 [PMID: 10655256 DOI: 10.1002/hep.510310213]
20. Mannucci PM. Abnormal hemostasis tests and bleeding in chronic liver disease: are they related? No. J Thromb Haemost 2006; 4: 721-723 [PMID: 16634735 DOI: 10.1111/j.1538-7836.2006.01886.x]
21. Bosch J, Reverter JC. The coagulopathy of cirrhosis: myth or reality? Hepatology 2005; 41: 434-435 [PMID: 15723321 DOI: 10.1002/hep.20639]
22. Caldwell SH, Hoffman M, Lisman T, Macik BG, Northup PG, Reddy KR, Tripodi A, Sanyal AJ. Coagulation disorders and hemostasis in liver disease: pathophysiology and critical assessment of current management. Hepatology 2006; 44: 1039-1046 [PMID: 17006940 DOI: 10.1002/hep.21303]
23. Monroe DM, Hoffman M. The coagulation cascade in cirrhosis. Clin Liver Dis 2009; 13: 1-9 [PMID: 19150304 DOI: 10.1016/j.cld.2008.09.014]
24. Tripodi A, Mannucci PM. Abnormalities of hemostasis in chronic liver disease: reappraisal of their clinical significance and need for clinical and laboratory research. J Hepatol 2007; 46: 727-733 [PMID: 17316874]
25. Ben-Ari Z, Osman E, Hutton RA, Burroughs AK. Disseminated intravascular coagulation in liver cirrhosis: fact or fiction? Am J Gastroenterol 1999; 94: 2977-2982 [PMID: 10520855]
26. Erkan O, Bozdayi AM, Disibeyaz S, Oguz D, Ozcan M, Bahar K, Karayalcin S, Ozden A, Bozkaya H, Yurdaydin C, Uzunalimoglu O. Thrombophilic gene mutations in cirrhotic patients with portal vein thrombosis. Eur J Gastroenterol Hepatol 2005; 17: 339-343 [PMID: 15716659]
27. Tripodi A, Primignani M, Lemma L, Chantarangkul V, Mannucci PM. Evidence that low protein C contributes to the procoagulant imbalance in cirrhosis. J Hepatol 2013; 59: 265-270 [PMID: 23583273 DOI: 10.1016/j.jhep.2013.03.036]
28. Valla DC. Thrombosis and anticoagulation in liver disease. Hepatology 2008; 47: 1384-1393 [PMID: 18318436 DOI: 10.1002/hep.22192]
29. Delahousse B, Labat-Debelleix V, Decalonne L, d'Alteroche L, Perarnau JM, Gruel Y. Comparative study of coagulation and thrombin generation in the portal and jugular plasma of patients with cirrhosis. Thromb Haemost 2010; 104: 741-749 [PMID: 20806106 DOI: 10.1160/TH10-01-0040]]
30. Tripodi A, Anstee QM, Sogaard KK, Primignani M, Valla DC. Hypercoagulability in cirrhosis: causes and consequences. J Thromb Haemost 2011; 9: 1713-1723 [PMID: 21729237 DOI: 10.1111/j.1538-7836.2011.04429.x]
31. Fisher NC, Wilde JT, Roper J, Elias E. Deficiency of natural anticoagulant proteins C, S, and antithrombin in portal vein thrombosis: a secondary phenomenon? Gut 2000; 46: 534-539 [PMID: 10716684]
32. Janssen HL, Meinardi JR, Vleggaar FP, van Uum SH, Haagsma EB, van Der Meer FJ, van Hattum J, Chamuleau RA, Adang RP, Vandenbroucke JP, van Hoek B, Rosendaal FR. Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study. Blood 2000; 96: 2364-2368 [PMID: 11001884]
33. Mahmoud AE, Elias E, Beauchamp N, Wilde JT. Prevalence of the factor V Leiden mutation in hepatic and portal vein thrombosis. Gut 1997; 40: 798-800 [PMID: 9245936]
34. Pasta L, Marrone C, D'amico M, Virdone R, D'amico G, Sammarco P, Fabiano C, Pagliaro L. MTHFR C677T mutations in liver cirrhosis with and without portal vein thrombosis. Liver Int 2006; 26: 269-270 [PMID: 16448467]
35. Gabr MA, Bessa SS, El-Zamarani EA. Portal vein thrombosis in Egyptian patients with liver cirrhosis: Role of methylenetetrahydrofolate reductase C677T gene mutation. Hepatol Res 2010; 40: 486-493 [PMID: 20374299 DOI: 10.1111/j.1872-034X.2010.00628.x]
36. Amitrano L, Guardascione MA, Ames PR, Margaglione M, Iannaccone L, Brancaccio V, Balzano A. Increased plasma prothrombin concentration in cirrhotic patients with portal vein thrombosis and prothrombin G20210A mutation. Thromb Haemost 2006; 95: 221-223 [PMID: 16493481]
37. Zocco MA, Di Stasio E, De Cristofaro R, Novi M, Ainora ME, Ponziani F, Riccardi L, Lancellotti S, Santoliquido A, Flore R, Pompili M, Rapaccini GL, Tondi P, Gasbarrini GB, Landolfi R, Gasbarrini A. Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development. J Hepatol 2009; 51: 682-689 [PMID: 19464747 DOI: 10.1016/j.jhep.2009.03.013]
38. Amitrano L, Guardascione MA, Ames PR. Coagulation abnormalities in cirrhotic patients with portal vein thrombosis. Clin Lab 2007; 53: 583-589 [PMID: 18257465]
39. Kinjo N, Kawanaka H, Akahoshi T, Tomikawa M, Yamashita N, Konishi K, Tanoue K, Shirabe K, Hashizume M, Maehara Y. Risk factors for portal venous thrombosis after splenectomy in patients with cirrhosis and portal hypertension. Br J Surg 2010; 97: 910-916 [PMID: 20474001 DOI: 10.1002/bjs.7002]
40. Giannini EG, Savarino V. Thrombocytopenia in liver disease. Curr Opin Hematol 2008; 15: 473-480 [PMID: 18695370 DOI: 10.1097/MOH.0b013e32830a9746]
41. Kercher KW, Carbonell AM, Heniford BT, Matthews BD, Cunningham DM, Reindollar RW. Laparoscopic splenectomy reverses thrombocytopenia in patients with hepatitis C cirrhosis and portal hypertension. J Gastrointest Surg 2004; 8: 120-126 [PMID: 14746844]
42. Hayashi PH, Mehia C, Joachim Reimers H, Solomon HS, Bacon BR. Splenectomy for thrombocytopenia in patients with hepatitis C cirrhosis. J Clin Gastroenterol 2006; 40: 740-744 [PMID: 16940889]
43. Akahoshi T, Tomikawa M, Kawanaka H, Furusyo N, Kinjo N, Tsutsumi N, Nagao Y, Hayashi J, Hashizume M, Maehara Y. Laparoscopic splenectomy with interferon therapy in 100 hepatitis-C-virus-cirrhotic patients with hypersplenism and thrombocytopenia. J Gastroenterol Hepatol 2012; 27: 286-290 [PMID: 21793908 DOI: 10.1111/j.1440-1746.2011.06870.x]
44. Hirooka M, Ishida K, Kisaka Y, Uehara T, Watanabe Y, Hiasa Y, Michitaka K, Onji M. Efficacy of splenectomy for hypersplenic patients with advanced hepatocellular carcinoma. Hepatol Res 2008; 38: 1172-1177 [PMID: 18631253 DOI: 10.1111/j.1872-034X.2008.00389.x]
45. Morihara D, Kobayashi M, Ikeda K, Kawamura Y, Saneto H, Yatuji H, Hosaka T, Sezaki H, Akuta N, Suzuki Y, Suzuki F, Kumada H. Effectiveness of combination therapy of splenectomy and long-term interferon in patients with hepatitis C virus-related cirrhosis and thrombocytopenia. Hepatol Res 2009; 39: 439-447 [PMID: 19207581 DOI: 10.1111/j.1872-034X.2008.00481.x]
46. Yoshida M, Watanabe Y, Horiuchi A, Yamamoto Y, Sugishita H, Kawachi K. Portal and splenic venous thrombosis after splenectomy in patients with hypersplenism. Hepatogastroenterology 2009; 56: 538-541 [PMID: 19579638]
47. Winslow ER, Brunt LM, Drebin JA, Soper NJ, Klingensmith ME. Portal vein thrombosis after splenectomy. Am J Surg 2002; 184: 631-635; discussion 635-636 [PMID: 12488196]
48. Amitrano L, Brancaccio V, Guardascione MA, Margaglione M, Sacco M, Martino R, De Nucci C, Mosca S, Iannaccone L, Ames PR, Romano L, Balzano A. Portal vein thrombosis after variceal endoscopic sclerotherapy in cirrhotic patients: role of genetic thrombophilia. Endoscopy 2002; 34: 535-538 [PMID: 12170404]
49. Politoske D, Ralls P, Korula J. Portal vein thrombosis following endoscopic variceal sclerotherapy. Prospective controlled comparison in patients with cirrhosis. Dig Dis Sci 1996; 41: 185-190 [PMID: 8565755]
50. Afdhal NH, Giannini EG, Tayyab G, Mohsin A, Lee JW, Andriulli A, Jeffers L, McHutchison J, Chen PJ, Han KH, Campbell F, Hyde D, Brainsky A, Theodore D. Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia. N Engl J Med 2012; 367: 716-724 [PMID: 22913681 DOI: 10.1056/NEJMoa1110709]
51. Dultz G, Kronenberger B, Azizi A, Mihm U, Vogl TJ, Sarrazin U, Sarrazin C, Zeuzem S, Hofmann WP. Portal vein thrombosis as complication of romiplostim treatment in a cirrhotic patient with hepatitis C-associated immune thrombocytopenic purpura. J Hepatol 2011; 55: 229-232 [PMID: 21310200 DOI: 10.1016/j.jhep.2011.01.020]
52. North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. N Engl J Med 1988; 319: 983-989 [PMID: 3262200 DOI: 10.1056/NEJM198810133191505]
53. Condat B, Vilgrain V, Asselah T, O'Toole D, Rufat P, Zappa M, Moreau R, Valla D. Portal cavernoma-associated cholangiopathy: a clinical and MR cholangiography coupled with MR portography imaging study. Hepatology 2003; 37: 1302-1308 [PMID: 12774008 DOI: 10.1053/jhep.2003.50232]
54. Khuroo MS, Dar MY, Yattoo GN, Khan BA, Boda MI, Zargar SA, Javid G, Allai MS. Serial cholangiographic appearances in recurrent pyogenic cholangitis. Gastrointest Endosc 1993; 39: 674-679 [PMID: 8224691 DOI: 10.1016/S0016-5107(93)70221-7]
55. Subramanyam BR, Balthazar EJ, Lefleur RS, Horii SC, Hulnick DH. Portal venous thrombosis: correlative analysis of sonography, CT and angiography. Am J Gastroenterol 1984; 79: 773-776 [PMID: 6385690]
56. Ueno N, Sasaki A, Tomiyama T, Tano S, Kimura K. Color Doppler ultrasonography in the diagnosis of cavernous transformation of the portal vein. J Clin Ultrasound 1997; 25: 227-233 [PMID: 9314103]
57. Bach AM, Hann LE, Brown KT, Getrajdman GI, Herman SK, Fong Y, Blumgart LH. Portal vein evaluation with US: comparison to angiography combined with CT arterial portography. Radiology 1996; 201: 149-154 [PMID: 8816536]
58. Chou CK, Mak CW, Tzeng WS, Chang JM. CT of small bowel ischemia. Abdom Imaging 2004; 29: 18-22 [PMID: 15160748 DOI: 10.1007/s00261-003-0073-3]
59. Lee HK, Park SJ, Yi BH, Yeon EK, Kim JH, Hong HS. Portal vein thrombosis: CT features. Abdom Imaging 2008; 33: 72-79 [PMID: 17694406 DOI: 10.1007/s00261-007-9200x]
60. Tublin ME, Dodd GD, Baron RL. Benign and malignant portal vein thrombosis: differentiation by CT characteristics. AJR Am J Roentgenol 1997; 168: 719-723 [PMID:9057522 DOI: 10.2214/ajr.168.3.9057522]
61. Maruyama H, Ishibashi H, Takahashi M, Shimada T, Kamesaki H, Yokosuka O. Prediction of the therapeutic effects of anticoagulation for recent portal vein thrombosis: a novel approach with contrast-enhanced ultrasound. Abdom Imaging 2012; 37: 431-438 [PMID: 21904887 DOI: 10.1007/s00261-011-9795-9]
62. Amitrano L, Guardascione MA, Menchise A, Martino R, Scaglione M, Giovine S, Romano L, Balzano A. Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis. J Clin Gastroenterol 2010; 44: 448-451 [PMID: 19730112 DOI: 10.1097/MCG.0b013e3181b3ab44]
63. Senzolo M, M Sartori T, Rossetto V, Burra P, Cillo U, Boccagni P, Gasparini D, Miotto D, Simioni P, Tsochatzis E, A Burroughs K. Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis. Liver Int 2012; 32: 919-927 [PMID: 22435854 DOI: 10.1111/j.1478-3231.2012.02785.x]
64. Maruyama H, Okugawa H, Takahashi M, Yokosuka O. De novo portal vein thrombosis in virus-related cirrhosis: predictive factors and long-term outcomes. Am J Gastroenterol 2013; 108: 568-574 [PMID: 23381015 DOI: 10.1038/ajg.2012.452]
65. Luca A, Caruso S, Milazzo M, Marrone G, Mamone G, Crinò F, Maruzzelli L, Miraglia R, Floridia G, Vizzini G. Natural course of extrahepatic nonmalignant partial portal vein thrombosis in patients with cirrhosis. Radiology 2012; 265: 124-132 [PMID: 22891357]
66. Lendoire J, Raffin G, Cejas N, Duek F, Barros Schelotto P, Trigo P, Quarin C, Garay V, Imventarza O. Liver transplantation in adult patients with portal vein thrombosis: risk factors, management and outcome. HPB (Oxford) 2007; 9: 352-356 [PMID: 18345318 DOI: 10.1080/13651820701599033]
67. Selvaggi G, Weppler D, Nishida S, Moon J, Levi D, Kato T, Tzakis AG. Ten-year experience in porto-caval hemitransposition for liver transplantation in the presence of portal vein thrombosis. Am J Transplant 2007; 7: 454-460 [PMID: 17229075]
68. Englesbe MJ, Kubus J, Muhammad W, Sonnenday CJ, Welling T, Punch JD, Lynch RJ, Marrero JA, Pelletier SJ. Portal vein thrombosis and survival in patients with cirrhosis. Liver Transpl 2010; 16: 83-90 [PMID: 20035521 DOI: 10.1002/lt.21941]
69. Rodríguez-Castro KI, Porte RJ, Nadal E, Germani G, Burra P, Senzolo M. Management of nonneoplastic portal vein thrombosis in the setting of liver transplantation: a systematic review. Transplantation 2012; 94: 1145-1153 [PMID: 23128996 DOI: 10.1097/TP.0b013e31826e8e53]
70. Doenecke A, Tsui TY, Zuelke C, Scherer MN, Schnitzbauer AA, Schlitt HJ, Obed A. Pre-existent portal vein thrombosis in liver transplantation: influence of pre-operative disease severity. Clin Transplant 2010; 24: 48-55 [PMID: 19236435 DOI: 10.1111/j.1399-0012.2009.00977.x]
71. Ramos AP, Reigada CP, Ataíde EC, Almeida JR, Cardoso AR, Caruy CA, Stucchi RS, Boin IF. Portal vein thrombosis and liver transplantation: long term. Transplant Proc 2010; 42: 498-501 [PMID: 20304176 DOI: 10.1016/j.transproceed.2010.01.038]
72. Bates SM, Ginsberg JS. Clinical practice. Treatment of deep-vein thrombosis. N Engl J Med 2004; 351: 268-277 [PMID: 15254285]
73. Delgado MG, Seijo S, Yepes I, Achécar L, Catalina MV, García-Criado A, Abraldes JG, de la Peña J, Bañares R, Albillos A, Bosch J, García-Pagán JC. Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis. Clin Gastroenterol Hepatol 2012; 10: 776-783 [PMID: 22289875 DOI: 10.1016/j.cgh.2012.01.012]
74. Arjal R, Trotter JF. International normalized ratio of prothrombin time in the model for end-stage liver disease score: an unreliable measure. Clin Liver Dis 2009; 13: 67-71 [PMID: 19150311 DOI: 10.1016/j.cld.2008.09.009]
75. Kovacs MJ, Wong A, MacKinnon K, Weir K, Keeney M, Boyle E, Cruickshank M. Assessment of the validity of the INR system for patients with liver impairment. Thromb Haemost 1994; 71: 727-730 [PMID: 7605424]
76. Clavien PA. Diagnosis and management of mesenteric in farction. Br J Surg 1990; 77: 601-603 [PMID: 2200547]
77. Kearon C, Kahn SR, Agnelli G, Goldhaber S, Raskob GE, Comerota AJ. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133: 454S-545S [PMID: 18574272 DOI: 10.1378/chest.08-0658]
78. Thatipelli MR, McBane RD, Hodge DO, Wysokinski WE. Survival and recurrence in patients with splanchnic vein thromboses. Clin Gastroenterol Hepatol 2010; 8: 200-205 [PMID: 19782767 DOI: 10.1016/j.cgh.2009.09.019]
79. Tripodi A, Mannucci PM. The coagulopathy of chronic liver disease. N Engl J Med 2011; 365: 147-156 [PMID: 21751907 DOI: 10.1056/NEJMra1011170]
80. Senzolo M, Ferronato C, Burra P, Sartori MT. Anticoagulation for portal vein thrombosis in cirrhotic patients should be always considered. Intern Emerg Med 2009; 4: 161-162; author reply 163-164 [PMID: 19130177 DOI: 10.1007/s11739-008-0219-y]
81. Villa E, Cammà C, Marietta M, Luongo M, Critelli R, Colopi S, Tata C, Zecchini R, Gitto S, Petta S, Lei B, Bernabucci V, Vukotic R, De Maria N, Schepis F, Karampatou A, Caporali C, Simoni L, Del Buono M, Zambotto B, Turola E, Fornaciari G, Schianchi S, Ferrari A, Valla D. Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis. Gastroenterology 2012; 143: 1253-1260.e1-4 [PMID: 22819864 DOI: 10.1053/j.gastro.2012.07.018]
82. Bechmann LP, Sichau M, Wichert M, Gerken G, Kröger K, Hilgard P. Low-molecular-weight heparin in patients with advanced cirrhosis. Liver Int 2011; 31: 75-82 [PMID: 20958919 DOI: 10.1111/j.1478-3231.2010.02358.x]
83. Kawanaka H, Akahoshi T, Kinjo N, Konishi K, Yoshida D, Anegawa G, Yamaguchi S, Uehara H, Hashimoto N, Tsutsumi N, Tomikawa M, Maehara Y. Impact of antithrombin III concentrates on portal vein thrombosis after splenectomy in patients with liver cirrhosis and hypersplenism. Ann Surg 2010; 251: 76-83 [PMID: 19864937 DOI: 10.1097/SLA.0b013e3181bdf8ad]
84. Francoz C, Valla D, Durand F. Portal vein thrombosis, cirrhosis, and liver transplantation. J Hepatol 2012; 57: 203-212 [PMID: 22446690 DOI: 10.1016/j.jhep.2011.12.034]
85. Luca A, Miraglia R, Caruso S, Milazzo M, Sapere C, Maruzzelli L, Vizzini G, Tuzzolino F, Gridelli B, Bosch J. Short-and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis. Gut 2011; 60: 846-852 [PMID: 21357252 DOI: 10.1136/gut.2010.228023]
86. D'Avola D, Bilbao JI, Zozaya G, Pardo F, Rotellar F, Iñarrairaegui M, Quiroga J, Sangro B, Herrero JI. Efficacy of transjugular intrahepatic portosystemic shunt to prevent total portal vein thrombosis in cirrhotic patients awaiting for liver transplantation. Transplant Proc 2012; 44: 2603-2605 [PMID: 23146469 DOI: 10.1016/j.transproceed.2012.09.050]
87. de Franchis R. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2010; 53: 762-768 [PMID: 20638742 DOI: 10.1016/j.jhep.2010.06.004]